Back
VictoryShares US Value Momentum ETF Vs. Cidara Therapeutics, Inc. Industry Stock Comparison
Buy
52
ULVM
VictoryShares US Value Momentum ETF
Last Price:
$93.00
Seasonality Move:
0.71%
Buy
80
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.73
Seasonality Move:
11.35%
Buy
52
VictoryShares US Value Momentum ETF (ULVM)
is a Buy
Is VictoryShares US Value Momentum ETF a Buy, Sell or Hold?
-
The current VictoryShares US Value Momentum ETF [ULVM] share price is $91.77. The Score for ULVM is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
ULVM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Cidara Therapeutics, Inc. [CDTX] share price is $220.80. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ULVM Stock Price Chart
What is VictoryShares US Value Momentum ETF's stock price today?
-
The VictoryShares US Value Momentum ETF share price today is $91.77Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ULVM is experiencing buying pressure, which is a positive indicator for future bullish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics, Inc.'s stock price today?
-
The Cidara Therapeutics, Inc. share price today is $220.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ULVM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 17.21 | Buy |
| Relative Strength Index (14 RSI): | 56.06 | Buy |
| Chaikin Money Flow: | 1207 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (89.75 - 92.17) | Buy |
| Bollinger Bands (100): | (87.36 - 91.02) | Buy |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.77 | Buy |
| Relative Strength Index (14 RSI): | 85.1 | Buy |
| Chaikin Money Flow: | 991653 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (219.01 - 220.61) | Buy |
| Bollinger Bands (100): | (55.63 - 178.69) | Buy |
ULVM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 91.79 | Sell |
| 20-day SMA: | 91.45 | Buy |
| 50-day SMA: | 90.33 | Buy |
| 200-day SMA: | 85.19 | Buy |
| 8-day EMA: | 48.46 | Buy |
| 20-day EMA: | 23.73 | Buy |
| 50-day EMA: | 10.35 | Buy |
| 200-day EMA: | 2.7 | Buy |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.26 | Buy |
| 20-day SMA: | 220.14 | Buy |
| 50-day SMA: | 161.87 | Buy |
| 200-day SMA: | 73.76 | Buy |
| 8-day EMA: | 220.14 | Buy |
| 20-day EMA: | 210.53 | Buy |
| 50-day EMA: | 173.33 | Buy |
| 200-day EMA: | 94.53 | Buy |
VictoryShares US Value Momentum ETF Earnings Growth & ULVM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.
VictoryShares US Value Momentum ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||